Limited use of cationic liposomes as tools to enhance the antiherpetic activities of oligonucleotides in Vero cells infected with herpes simplex virus type 1

Antisense and Nucleic Acid Drug Development

Volumn 8, Issue 4, 1998, Pages 255-263

  Shoji, Yoko ^a,b   Norimatsu, Miki ^a   Shimada, Jingoro ^a   Mizushima, Yutaka ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; ANTISENSE OLIGONUCLEOTIDE; CATION; LIPOSOME; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; LASER MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; VERO CELL;

ANIMALIA; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1;

EID: 0031695667     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1998.8.255     Document Type: Article

References (28)

1. AKHTAR, S., SHOJI, Y., and JULIANO, R.L. (1992). Pharmaceutical aspects of the biological stability and membrane transport characteristics of antisense oligonucleotides. In: Gene Regulation: Biology of Antisense RNA and DNA. R.P. Erickson and J.G. Izant, eds. (Raven Press, New York), pp. 133-145.
2. ASSELINE, U., GEISER, T., and ZON, G. (1989). Synthesis of antisense phosphorothioate analogues for pharmacokinetics and preclinical studies. Nucleosides Nucleotides 8, 967-970.
3. BENNETT, C.F., CHANG, M.-Y., CHAN, H., SHOEMAKER, J.E.E., and MIRABELLI, C.K. (1992). Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41, 1023-1033.
4. BISHOP, J.S., GUY-CAFFEY, J.K., OJWANG, J.O., SMITH, S.R., HOGAN, M.E., COSSUM, P.A., RANDO, R.F., and CHAUDHARY, N. (1996). Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide. J. Biol. Chem. 271, 5698-5703.
5. BUCKHEIT, R.W., ROBERTSON, J.L., LACKMAN, S.C., WYATT, J.R., VICKERS, T.A., and ECKER, D.J. (1994). Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). AIDS Res. Hum. Retrovir. 10, 1497-1506.
6. CARMICHAEL, J., DEGRAFF, W.G., GAZDAR, A.F., MINNA, J.D., and MITCHELL, J.B. (1987). Evaluation of a tetrazolium based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 47, 936-942.
7. CHIANG, M.-Y., CHAN, H., ZOUNES, M.A., FREIER, S.M., LIMA, W.F., and BENNET, C.F. (1991). Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266, 18162-18171.
8. FARRELL, C.L., BREADY, J.V., KAUFMAN, S.A., QUIAN, Y.X., and BURGESS, T.L. (1995). The uptake and distribution of phosphorothioate oligonucleotides into vascular smooth muscle cells in vitro and in rabbit arteries. Antisense Res. Dev. 5, 175-183.
9. FELGNER, P.L., GADEK, T.R., HOLM, M., ROMAN, R., CHAN, H.W., WENZ, M., NORTHROP, J.P., RINGOLD, G.M., and DANIELSEN, M. (1987). Lipofectin: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84, 7413-7417.
10. FREIER, S.M., KIERZEK, R., JAEGER, J.A., SUGIMOTO, N., CARUTHERS, M.H., NEILSON, T., and TURNER, D.H. (1986). Improved free-energy parameters for prediction of RNA duplex stability. Proc. Natl. Acad. Sci. USA 83, 9373-9377.
11. GAO, W.Y., HANES, R.N., VAZQUEZ-PADUA, M.A., STEIN, C.A., COHEN, J.S., and CHENG, Y.C. (1990). Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides. Antimicrob. Agents Chemother. 34, 808-812.
12. GAO, X., and HUANG, L. (1995). Cationic liposome-mediated gene transfer. Gene Ther. 2, 710-722.
13. GAUGUIN, S.E., YEGER, H., and IGARASHI, P. (1997). Antisense oligonucleotides to Cux-1, a Cut-related homeobox gene, caused increased apoptosis in mouse embryonic kidney cultures. J. Clin. Invest. 99, 718-724.
14. IVERSEN, P.L., ZHU, S., MEYRE, A., and ZON, G. (1992). Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells. Antisense Res. Dev. 2, 211-222.
15. LAPPALAINEN, K., URTTI, A., SERLING, E., JOSKELUNEN, I., SYRJUEN, K., and SYRJUEN, S. (1994). Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells. Biochim. Biophys. Acta 1196, 201-208.
16. LIU, Y., MOUNKES, L.C., LIGGITT, H.D., BROWN, C.S., SOLODIN, I., HEATH, T.D., and DEBS, R.J. (1997). Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat. Biotechnol. 15, 167-173.
17. LOKE, S.L., STEIN, C.A., ZHANG, X.H., MORI, K., NAKANISHI, M., SUBASINGHE, C., COHEN, J.S., and NECKERS, L.M. (1989). Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA 86, 3474-3478.
18. MATSUKURA, M., SHINOZUKA, K., ZON, G., MITSUYA, H., REITZ, M., COHEN, J.S., and BRODER, S. (1987). Phosphorothioate analogues of oligodeoxynucleotides: Inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 84, 7706-7710.
19. SHOJI, Y., DOKEN, I., SHIMADA, J., and MIZUSHIMA, Y. (1995). The factors to reflect on the subcellular distribution of antisense DNA. Drug Deliv. Syst. 10, 85-89.
20. SHOJI, Y., ISHIGE, H., TAMURA, N., IWATANI, W., NORI-MATSU, M., SHIMADA, J., and MIZUSHIMA, Y. (1998). Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5′ end modified with geraniol. J. Drug Targeting, In press.
21. STAMATATOS, L., LEVENTIS, R., ZUCKERMANN, M.J., and SILVIUS, J.R. (1988). Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes. Biochemistry 27, 3917-3925.
22. STEIN, C.A., and CHENG, Y.-C. (1993). Antisense oligonucleotides as therapeutic agents - Is the bullet really magical? Science 261, 1004-1012.
23. STOREY, A., DATES, D., BANKS, L., CRAWFORD, L., and VROOK, T. (1991). Antisense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16. Nucleic Acids Res. 19, 4109-4114.
24. SUGIMOTO, N., NAKANO, S., KATOH, M., MATSUMURA, A., NAKAMUTA, H., OHMICHI, T., YONEYAMA, M., and SASAKI, M. (1995). Thermodynamic parameters to predict stability of RNA.DNA hybrid duplexes. Biochemistry 34, 11211-11216.
25. TAMURA, N., IWATANI, W., SHOJI, Y., NORIMATSU, M., SHIMADA, J., and MIZUSHIMA, Y. (1994). Antiviral effects of phosphorothioate oligonucleotides complementary to 3′ splice regions of herpes simplex virus immediate early pre-mRNA5. Nucleic Acids Symp. Ser. 31, 73-74.
26. TAYLOR, M.F., PAULAUSKIS, J.D., WELLER, D.D., and KOBZIK, L. (1996). In vitro efficacy of morpholino-mediated antisense oligomers directed against tumor necrosis factor-alpha mRNA. J. Biol. Chem. 271, 17445-17452.
27. WAGNER, R.W. (1994). Gene inhibition using antisense oligonucleotides. Nature 372, 333-335.
28. ZELPHATI, O., and SZOKA, F.C., JR. (1996). Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA 93, 11493-11498.